Vickie S Reed Mirati Therapeutics, Inc. (MRTX) insider trading activity

Vickie S Reed is SVP, Chief Accounting Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 15,369 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 18, 2022, when has been sold 533 shares (Common Stock) at a price of $120.48 per share, resulting in proceeds of $64,216. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.4K

0% 3M change

0% 12M change

Total Value Held $0

VICKIE S REED Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 18 2022	SELL Open market or private sale	$64,216 $120.48 p/Share	533 Reduced 3.35%	15,369 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	5,377 Added 25.27%	15,902 Common Stock
Jan 07 2022	SELL Open market or private sale	$46,899 $135.94 p/Share	345 Reduced 3.17%	10,525 Common Stock
Jan 04 2022	SELL Open market or private sale	$111,987 $147.74 p/Share	758 Reduced 6.52%	10,870 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	4,157 Added 26.34%	11,628 Common Stock
Jan 07 2021	SELL Open market or private sale	$52,136 $216.33 p/Share	241 Reduced 3.13%	7,471 Common Stock
Jan 06 2021	SELL Open market or private sale	$114,589 $212.99 p/Share	538 Reduced 6.52%	7,712 Common Stock

Also insider at

EVOK

Evoke Pharma Inc Healthcare

ADMP

Adamis Pharmaceuticals Corp Healthcare

Director

VSR

Vickie S Reed

SVP, Chief Accounting Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX

Account